Citigroup Inc Cytek Biosciences, Inc. Transaction History

Citigroup Inc

$163 Billion
Q4 2024

A detailed history of Citigroup Inc transactions in Cytek Biosciences, Inc. stock. As of the latest transaction made, Citigroup Inc holds 160,195 shares of CTKB stock, worth $716,071. This represents 0.0% of its overall portfolio holdings.

Number of Shares

160,195

Previous 141,619 13.12%

Holding current value

$716,071

Previous $784,000 32.53%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	BUY	$4.7 - $7.4 $87,307 - $137,462	18,576 Added 13.12%	160,195 $1.04 Million
Q3 2024 Nov 12, 2024	BUY	$4.73 - $6.73 $305,382 - $434,508	64,563 Added 83.79%	141,619 $784,000
Q2 2024 Aug 12, 2024	BUY	$5.3 - $6.91 $68,513 - $89,325	12,927 Added 20.16%	77,056 $429,000
Q1 2024 May 10, 2024	BUY	$6.29 - $9.15 $19,341 - $28,136	3,075 Added 5.04%	64,129 $430,000
Q4 2023 Feb 09, 2024	BUY	$4.1 - $9.51 $93,820 - $217,617	22,883 Added 59.95%	61,054 $556,000
Q3 2023 Nov 09, 2023	SELL	$5.52 - $9.5 $175,563 - $302,147	-31,805 Reduced 45.45%	38,171 $210,000
Q2 2023 Aug 10, 2023	BUY	$6.69 - $11.99 $401,895 - $720,287	60,074 Added 606.69%	69,976 $597,000
Q1 2023 May 11, 2023	BUY	$8.44 - $13.47 $62,320 - $99,462	7,384 Added 293.25%	9,902 $90,000
Q4 2022 Feb 09, 2023	SELL	$9.71 - $15.86 $9,496 - $15,511	-978 Reduced 27.97%	2,518 $25,000
Q3 2022 Nov 10, 2022	SELL	$10.96 - $15.45 $61,408 - $86,566	-5,603 Reduced 61.58%	3,496 $52,000
Q2 2022 Aug 10, 2022	BUY	$7.41 - $11.56 $34,478 - $53,788	4,653 Added 104.66%	9,099 $97,000
Q1 2022 May 12, 2022	BUY	$9.89 - $17.25 $2,719 - $4,743	275 Added 6.59%	4,446 $48,000
Q4 2021 Feb 10, 2022	BUY	$16.14 - $25.04 $31,376 - $48,677	1,944 Added 87.29%	4,171 $68,000
Q3 2021 Nov 10, 2021	BUY	$17.52 - $27.93 $39,017 - $62,200	2,227 New	2,227 $48,000

Others Institutions Holding CTKB

# of Institutions

151

Shares Held

74M

Call Options Held

Put Options Held

View Full List

About Cytek Biosciences, Inc.

Ticker CTKB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 134,627,008
Market Cap $602M
Description
Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers ...

More about CTKB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account